Download Citation
Article Source:
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network
Voskens CJ,
Goldinger SM,
Loquai C,
Robert C,
Kaehler KC,
et al.
(2013)
The Price of Tumor Control: An Analysis of Rare Side Effects of Anti-CTLA-4 Therapy in Metastatic Melanoma from the Ipilimumab Network.
PLOS ONE 8(1): e53745.
https://doi.org/10.1371/journal.pone.0053745